Evidence map›Paper›PMID 38473236›Full record

ArticleCancers2024

Bruna Pereira Sorroche, Keila Cristina Miranda, Caroline Moraes Beltrami, Lidia Maria Rebolho Batista Arantes, Luiz Paulo Kowalski, Fabio Albuquerque Marchi, Silvia Regina Rogatto, Janete Dias Almeida

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. The role of HOXA1 in cancer and targeted therapy.Medical oncology (Northwood, London, England) · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Bruna Pereira SorrocheMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil.ORCID 0000-0001-9802-8236
Keila Cristina MirandaDepartment of Biosciences and Oral Diagnosis, Institute of Science and Technology, São Paulo State University (UNESP), São José dos Campos 12224-300, Brazil.
Caroline Moraes BeltramiInternational Research Center, A.C. Camargo Cancer Center, São Paulo 01508-010, Brazil.
Lidia Maria Rebolho Batista ArantesMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, Brazil.ORCID 0000-0001-8230-1218
Luiz Paulo KowalskiHead and Neck Surgery and Otorhinolaryngology Department, AC Camargo Cancer Center, Latin American Cooperative Oncology Group, São Paulo 01509-010, Brazil.
Fabio Albuquerque MarchiCenter for Translational Research in Oncology, Cancer Institute of the State of São Paulo (ICESP), São Paulo 01246-000, Brazil.
Silvia Regina RogattoDepartment of Clinical Genetics, University Hospital of Southern Denmark, 7100 Vejle, Denmark.ORCID 0000-0003-4637-5687
Janete Dias AlmeidaDepartment of Biosciences and Oral Diagnosis, Institute of Science and Technology, São Paulo State University (UNESP), São José dos Campos 12224-300, Brazil.ORCID 0000-0003-4596-9715
Hospital de Câncer de Barretos · BRUniversidade de São Paulo · BRUniversidade Estadual Paulista (Unesp) · BRAC Camargo Hospital · BRUniversity of Southern Denmark · DK

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/08633-0
6 · The paper itself

Abstract

background

methodsThe

resultsCompared to normal tissues, we found significantly higher DNA methylation levels in the 3'UTR region of

conclusionsOur findings suggest that

Indexed as

DNA methylationhead and neck cancerHOXA1oral squamous cell carcinomatumor suppressor gene

Identifiers

PMID38473236
PMCPMC10930908
OpenAlexW4392110492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.